The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
John C. Carter, MD1,2; Anne Marie Morse, DO3; Michael J. Thorpy, MD4; Bruce C. Corser, MD5; Sally Ibrahim, MD1,6; Maria Picone7; Angeni Cordova, MPH7; Lauren Dougherty7; Jacqueline Brooks, MBBCh, MRCPsych8; Jennifer Gudeman, PharmD9,a
1Case Western Reserve University School of Medicine, Cleveland, OH, USA; 2The MetroHealth System, Cleveland, OH, USA; 3Geisinger Commonwealth School of Medicine, Geisinger Medical Center, Janet Weis Children’s Hospital, Danville, PA, USA; 4Albert Einstein College of Medicine, New York, NY, USA; 5Sleep Management Institute, Cincinnati, OH, USA; 6University Hospitals Cleveland Medical Center, Cleveland, OH, USA; 7TREND Community, Philadelphia, PA, USA; 8Alkermes, Inc., Waltham, MA*, USA; 9Avadel Pharmaceuticals, Chesterfield, MO, USA; aAt the time of the study
